Search Results

GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement is indicated for use in surgical procedures in which soft tissue transection or resection with staple line reinforcement is needed. It can be used for reinforcement of staple lines during hysterectomy, lung resection, bladder reconstruction, bronchial, bariatric, colon, colorectal, esophagus, gastric, mesentery, pancreas, small bowel, and spleen procedures. It is also intended to be used for remforcement of suture lines and staple lines (i.e., occlusion of the left atrial appendage during open chest procedures) during cardiac surgery.

The subject of this 510(k) pre-market notification is a modification to the GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement Material Configured for Endoscopic Surgical Staplers (EBSG, also referred to as the predicate) to include altered bioabsorbable sheet geometries, tailored lattice stitching, and inner dimension geometry for both the cartridge and anvil devices. The cartridge and anvil devices were specifically designed to fit the geometry of the Intuitive SureForm 60™ mm staplers (K173721 cleared July 5, 2018) Black, Green and Blue cartridge reloads. GORE® SEAMGUARD® Reinforcement Bioabsorbable Staple Line Reinforcement Configured for Intuitive Surgical® Robotic Endoscopic Surgical Staplers (EBSG-R, also referred to as the modified device) possesses the same fundamental scientific technology as the predicate. No other physical modifications were made to the predicate device, and the implantable materials of the modified device and predicate are the same synthetic bioabsorbable poly (glycolide: trimethylene carbonate) copolymer (PGA:TMC).

The provided text describes a 510(k) premarket notification for a medical device, the GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement. However, it does not contain information about a study that assesses the performance of an AI-powered device against specific acceptance criteria, nor does it detail and of the requirements listed in points 2-9 of your prompt.

The document is a regulatory submission for a physical medical device (a staple line reinforcement material), not a software or AI device. Therefore, it focuses on demonstrating substantial equivalence to a predicate device through pre-clinical bench testing, and explicitly states that "No clinical evaluations were required to support this submission."

As such, it is not possible to extract the requested information (acceptance criteria for an AI device, sample sizes, expert qualifications, MRMC study details, ground truth methods, training set details) from this document.

Ask a specific question about this device